Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?

  1. Gutiérrez-Larrañaga, M.
  2. González-López, E.
  3. Roa-Bautista, A.
  4. Rodrigues, P.M.
  5. Diáz-González, Á.
  6. Banales, J.M.
  7. López-Hoyos, M.
  8. Santos-Laso, A.
  9. Crespo, J.
Revue:
Liver Cancer

ISSN: 1664-5553 2235-1795

Année de publication: 2021

Volumen: 10

Número: 6

Pages: 545-560

Type: Révision

DOI: 10.1159/000518104 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable